Clinical TrialsSearch results
Number of results: 1286
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A research study comparing how well different doses of the medicine NNC0519-0130 help people with excess body weight lose weight(NN9541-5015)
- Obesity
- Oyatani Akihito
- 2024-03-11
Other
- A retrospective, 12-month, multicenter study to evaluate real-world brolucizumab effectiveness and safety in Japanese patients with neovascular age-related macular degeneration (nAMD)
- neovascular Age-related Macular Degeneration
- Takuma Okada
- 2022-01-22
Other
- A sing le-arm, phase I study of ramucirumab in combination with erlotinib or osimertinib in previously untreated patients with EGFR mutantion-posit ive metastatic Non-small cell lung cancer with brain metastases
- lung carcinoma, non small cell
- Kaneda Hiroyasu
- 2019-06-21
Other
- A single center, phase 2 study to evaluate safety and efficacy of total neoadjuvant treatment of short course radiotherapy followed by chemotherapy, capecitabine combined with oxaliplatin (CAPOX) for locally advanced rectal cancer
- Rectal cancer
- Kagawa Yoshinori
- 2021-01-19
Other
- A single-center, open-label, uncontrolled study to evaluate the safety and tolerability of EVA101 with non-oxygenated perfluorodecalin (PFD) in healthy male volunteers
- Healthy Male Subjects
- Chihiro Yokota
- 2024-05-30
Other
- A Single/Multiple Dose Study of SSJG-009 (Phase I)
- Healthy Japanese adult males
- Fujisawa Kouichi
- 2024-09-27
Other
- A study in healthy male and female participants of non-childbearing potential who have overweight or obesity
- Healthy Participants
- Ageishi Yuji
- 2024-07-09
Other
- A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
- Impaired glucose tolerance (IGT)
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- A Study of Lazertinib with Subcutaneous Amivantamab Compared with Intravenous Amivantamab in Participants with Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
- Advanced or Metastatic Non-Small Cell Lung Cancer
- Nakama Takahiro
- 2022-08-13
Other
- A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
- Heart Failure , Heart Failure With Preserved Ejection Fraction
- Masaki Takeshi
- 2022-12-13